60 results on '"Kletter, Kurt"'
Search Results
2. Light-dependent alteration of serotonin-1A receptor binding in cortical and subcortical limbic regions in the human brain.
- Author
-
Spindelegger, Christoph, Stein, Patrycja, Wadsak, Wolfgang, Fink, Martin, Mitterhauser, Markus, Moser, Ulrike, Savli, Markus, Mien, Leonhard-Key, Akimova, Elena, Hahn, Andreas, Willeit, Matthaeus, Kletter, Kurt, Kasper, Siegfried, and Lanzenberger, Rupert
- Subjects
CLIMATOLOGY ,AFFECTIVE disorders ,LIMBIC system ,BRAIN research ,SEROTONINERGIC mechanisms ,SEROTONIN transporters ,HUMAN experimentation ,PSYCHOLOGY - Abstract
Objective. Climate, in particular sunshine, influences mood and energy levels, creating a positive upswing of mood on bright, sunny days and negative downswing in cold, dark winter seasons. Higher serotonin transporter availability in healthy human subjects in times of lesser light exposure and lower serotonin levels have been shown in winter. Methods. We examined the light-dependent variations in serotonin-1A receptor binding in limbic regions in 36 drug-naive healthy human subjects. Receptor binding was quantified using positron emission tomography and the radioligand [ carbonyl-
11 C]WAY-100635. Binding potential values were related to the amount of individual exposure to sunlight (daily duration of sunshine) and global radiation (total light intensity). Results. We found a 20-30% lower serotonin-1A receptor binding in the group exposed to a lower amount of global light radiation. Partial correlation analysis revealed significant positive correlations between the regional postsynaptic serotonin-1A receptor binding and global radiation accumulated over a period of 5 days. Conclusions. Seasonal factors, such as daily amount of sunshine and global radiation, influence serotonin-1A receptor binding in limbic brain regions of healthy human subjects. Combined with recently demonstrated seasonal fluctuations in the serotonin transporter availability, our results underline the importance of seasonal factors in the regulation of the serotonergic transmission. [ABSTRACT FROM AUTHOR]- Published
- 2012
- Full Text
- View/download PDF
3. Coronary Vasoreactivity in Subjects with Thyroid Autoimmunity and Subclinical Hypothyroidism Before and After Supplementation with Thyroxine.
- Author
-
Traub-Weidinger, Tatjana, Graf, Senta, Beheshti, Mohsen, Ofluoglu, Sedat, Zettinig, Georg, Khorsand, Aliasghar, Nekolla, Stephan G., Kletter, Kurt, Dudczak, Robert, and Pirich, Christian
- Subjects
HYPOTHYROIDISM treatment ,POSITRON emission tomography ,CARDIOVASCULAR diseases risk factors ,LEVOTHYROXINE ,AUTOIMMUNITY ,THYROTROPIN ,BLOOD flow - Abstract
Background: The association of subclinical hypothyroidism (SCH) with increased risk for cardiovascular disease is still controversial. This study aimed to examine coronary vascular reactivity by positron emission tomography (PET) in asymptomatic patients with SCH before and after levothyroxine (LT4) supplementation. Methods: Ten patients (7 women and 3 men; mean age 43±15 years) with untreated autoimmune SCH, defined by elevated levels of thyroid-stimulating hormone (mean TSH: 16.9±11.3 μU/mL), normal levels of free thyroxine (0.9±0.1 μg/mL), free triiodothyronine (3.2±0.4 pg/mL), and positive thyroid peroxidase antibodies were studied. Eight euthyroid subjects with similar low-risk cardiovascular risk profile served as controls. Myocardial blood flow (MBF) and coronary flow reserve (CFR) were quantitatively assessed with rest/stress N-13 ammonia PET at baseline and after 6 months of LT4 replacement therapy (given only to patients). Results: At baseline, stress MBF and CFR corrected (c) for rate pressure product (RPP) and myocardial vascular resistance (MVR) during stress were significantly reduced in SCH compared with controls (stress MBF: 2.87±0.93 vs. 4.79±1.16 mL/g/min, p=0.003; CFR: 2.6±0.73 vs. 4.66±1.38, p=0.004; MVR: 40.14±18.76 vs. 20.47±6.24 mmHg/mL/min, p=0.02). Supplementation therapy with LT4 normalized TSH in all subjects and was associated with an increase in CFR (2.6±0.73 vs. 3.81±1.19, p=0.003) and with a tendency toward a decrease in MVR. Differences in CFR between SCH and controls were also seen after correction of resting MBF for RPP. Conclusions: In asymptomatic subjects with SCH due to thyroid autoimmunity, coronary microvascular function is impaired and improves after supplementation with LT4. This may partially explain the increased cardiovascular risk attributed to SCH. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
4. Plasma pharmacokinetics and gastrointestinal transit of a new Propionyl- l-Carnitine controlled release formulation.
- Author
-
Wagner, Claudia C., Rusca, Antonio, Kletter, Kurt, Tschurlovits, Manfred, Pace, Silvia, Longo, Antonio, Pedrani, Massimo, Villa, Roberto, Frimonti, Enrico, Müller, Markus, and Brunner, Martin
- Subjects
PHARMACOKINETICS ,GASTROINTESTINAL system ,CASE studies ,DRUG administration ,CARNITINE ,CONTROLLED release drugs ,FATTY acids - Abstract
Propionyl-l-carnitine is a naturally occurring analogue of l-carnitine (LC) produced in the body. PLC administration has shown beneficial effects in cardiovascular pathologies. In ulcerative colitis (UC), oral PLC treatment increased clinical presentation and positively influenced colon histology. In the present study, the MMX Multi Matrix System
® (MMX™) was used as drug delivery strategy for targeted PLC colon delivery. A pharmacoscintigraphic study (n = 6 healthy volunteers) described release characteristics of two MMX-PLC-HCl controlled release 500 mg tablets. A pharmacokinetic (PK) parallel group study (n = 24) determined safety, plasma PLC concentrations and PK parameters after single and multiple doses. Gastrointestinal transit was slow and variable. The colon was the main site of PLC release and absorption. After single 500 or 1000 mg PLC doses plasma PLC and LC increased up to 2.6 and 1.2–1.3-fold compared to baseline. Multiple doses of 500 and 1000 mg twice a day over 7 days did not significantly increase maximum plasma concentrations of PLC or LC with respect to concentrations achieved after single dose administration. The colon is the main site of PLC release and absorption from MMX-PLC tablets. A daily dose of 500 mg to 1000 mg PLC twice a day was well tolerated, justifying further studies in patients with pathologies of the distal gastrointestinal tract to evaluate the efficacy of the MMX-PLC formulation. [ABSTRACT FROM AUTHOR]- Published
- 2011
- Full Text
- View/download PDF
5. Progesterone Level Predicts Serotonin-1A Receptor Binding in the Male Human Brain.
- Author
-
Lanzenberger, Rupert, Mitterhauser, Markus, Kranz, Georg S., Spindelegger, Christoph, Wadsak, Wolfgang, Stein, Patrycja, Moser, Ulrike, Savli, Markus, Kletter, Kurt, and Kasper, Siegfried
- Subjects
PROGESTERONE ,SEROTONIN ,POSITRON emission tomography ,HYDROCORTISONE ,BRAIN ,MEN - Abstract
Background: Progesterone (P) is thought to influence mood and affective states. Alterations of the inhibitory serotonin-1A (5-HT
1A ) receptor distribution are associated with depression and anxiety. This study evaluates the influence of plasma P levels on the 5-HT1A receptor binding in healthy male subjects. Methods: Molecular neuroimaging of the 5-HT1A receptor distribution using positron emission tomography and hormone assays for total plasma P and cortisol were done in a sample of 18 healthy men. Results: Plasma P levels explained up to 65% of the variability in 5-HT1A receptor binding in limbic regions including the amygdala, orbitofrontal cortex and retrosplenial cortex. When controlling for cortisol in the model, there was an expected decline in explained variances of 5-HT1A binding attributed to P. Conclusions: The results of this study provide further support for the effect of P on 5-HT1A receptor expression and raise the possibility that P mediates the vulnerability to mood disorders by affecting the serotonergic system. Copyright © 2011 S. Karger AG, Basel [ABSTRACT FROM AUTHOR]- Published
- 2011
- Full Text
- View/download PDF
6. Cortisol plasma levels in social anxiety disorder patients correlate with serotonin-1A receptor binding in limbic brain regions.
- Author
-
Lanzenberger, Rupert, Wadsak, Wolfgang, Spindelegger, Christoph, Mitterhauser, Markus, Akimova, Elena, Mien, Leonhard-Key, Fink, Martin, Moser, Ulrike, Savli, Markus, Kranz, Georg S., Hahn, Andreas, Kletter, Kurt, and Kasper, Siegfried
- Subjects
SOCIAL phobia ,GLUCOCORTICOIDS ,SEROTONINERGIC mechanisms ,ANXIETY disorders ,MENTAL depression ,HYDROCORTISONE - Abstract
Dysregulation of the hypothalamic-pituitary-adrenocortical axis with deficient glucocorticoid feedback and alterations in the serotonergic system have been identified as biological correlates of mood disorders. Close examination of the interaction between these systems may offer insights into the pathophysiology of anxiety disorders and depression to understand how stress and these disorders are related. In this study, we investigated the relationship between plasma levels of cortisol and the dominant inhibitory serotonergic receptor, serotonin-1A (5-HT
1A ). Using positron emission tomography (PET) and the radioligand [carbonyl-11 C]WAY-100635, we quantified the 5-HT1A receptor binding. Data from 12 male patients with social phobia and 18 matched control subjects were analysed. Seven brain regions were investigated: the anterior and posterior cingulate cortices, hippocampus, amygdala, medial orbitofrontal and retrosplenial cortices, and dorsal raphe nucleus. Partial correlation analysis, controlled for age and radiochemical variables, was performed to demonstrate the association between cortisol plasma levels and 5-HT1A receptor binding. Cortisol plasma levels were significantly lower in patients with social phobia compared to healthy controls. Moreover, we found strong negative correlations between cortisol plasma levels and 5-HT1A binding in the amygdala (r=x0.93, p=0.0004), hippocampus (r=x0.80, p=0.009), and retrosplenial cortex (r=x0.48, p=0.04) in patients with social phobia. Within the former two regions, these associations were significantly higher in patients than in healthy controls. This PET study confirms a negative association between plasma cortisol levels and the 5-HT1A receptor distribution consistent with studies in rodents and non-human primates. Dysregulation of the cortisol level might increase the vulnerability for mood disorders by altering limbic 5-HT1A receptors. [ABSTRACT FROM AUTHOR]- Published
- 2010
- Full Text
- View/download PDF
7. Evaluating repetitive 18F-fluoroazomycin-arabinoside (18FAZA) PET in the setting of MRI guided adaptive radiotherapy in cervical cancer.
- Author
-
Schuetz, Matthias, Schmid, Maximilian P., Pötter, Richard, Kommata, Spyridoula, Georg, Dietmar, Lukic, Dobrica, Dudczak, Robert, Kletter, Kurt, Dimopoulos, Johannes, Karanikas, Georgios, and Bachtiary, Barbara
- Subjects
ANALYSIS of variance ,HYPOXEMIA ,CERVICAL cancer ,FLUORINE isotopes ,IMIDAZOLES ,MAGNETIC resonance imaging ,COMPUTERS in medicine ,HEALTH outcome assessment ,RADIATION doses ,RADIOISOTOPES ,POSITRON emission tomography ,QUALITATIVE research ,PILOT projects ,QUANTITATIVE research ,TREATMENT effectiveness ,PHARMACOKINETICS ,RADIOGRAPHY ,RADIOTHERAPY - Abstract
Background. The aim of this pilot study was to assess tumour hypoxia in patients with cervical cancer before, during and after combined radio-chemotherapy and Magnetic Resonance Imaging (MRI) guided brachytherapy (BT) by use of the hypoxia Positron Emission Tomography (PET) tracer
18 F-fluoroazomycin-arabinoside (18 FAZA ). Material and methods. Fifteen consecutive patients with locally advanced cervical cancer referred for definitive radiotherapy (RT) were included in an approved clinical protocol. Stage distribution was 3 IB1, 1 IB2, 10 IIB, 1 IIIB, tumour volume was 55 cm3 (+/− 67, SD). Dynamic and static18 FAZA -PET scans were performed before, during and after external beam therapy (EBRT) and image guided BT +/− concomitant cisplatin. Dose was prescribed to the individual High Risk Clinical Target Volume (HR CTV) taking into account the dose volume constraints for adjacent organs at risk. Results. Five patients had visually identifiable tumours on18 FAZA -PET scans performed prior to radio-chemotherapy and four patients before brachytherapy. One of five18 FAZA PET positive patients had incomplete remission three months after RT, one had regional recurrence. Four of ten18 FAZA-PET negative patients developed distant metastases. The one patient with incomplete remission received 69 Gy (D90) in the HR CTV, whereas all other patients received mean 99 Gy (+/−12, SD). Conclusion. PET imaging with18 FAZA is feasible in patients with cancer of the uterine cervix. However, its predictive and prognostic value remains to be clarified. This applies in particular for the additional value of18 FAZA-PET compared to morphologic repetitive MRI within the setting of image guided high dose radiotherapy which may contribute to overcome hypoxia related radioresistance. [ABSTRACT FROM AUTHOR]- Published
- 2010
- Full Text
- View/download PDF
8. Assessment of regional differences in tariquidar-induced P-glycoprotein modulation at the human blood–brain barrier.
- Author
-
Bauer, Martin, Karch, Rudolf, Neumann, Friederike, Wagner, Claudia C., Kletter, Kurt, Müller, Markus, Löscher, Wolfgang, Zeitlinger, Markus, and Langer, Oliver
- Subjects
GLYCOPROTEINS ,POSITRON emission tomography ,STATISTICS ,BRAIN ,BLOOD-brain barrier - Abstract
We attempted to assess regional differences in cerebral P-glycoprotein (P-gp) function by performing paired positron emission tomography (PET) scans with the P-gp substrate (R)-[
11 C]verapamil in five healthy subjects before and after i.v. infusion of tariquidar (2 mg/kg). Comparison of tariquidar-induced changes in distribution volumes (DVs) in 42 brain regions of interest (ROIs) failed to detect significant differences among brain ROIs. Statistical parametric mapping analysis of parametric DV images visualized symmetrical bilateral clusters with moderately higher DV increases in response to tariquidar administration in cerebellum, parahippocampal gyrus, olfactory gyrus, and middle temporal lobe and cortex, which might reflect moderately decreased P-gp function and expression. [ABSTRACT FROM AUTHOR]- Published
- 2010
- Full Text
- View/download PDF
9. A Pilot Study to Assess the Efficacy of Tariquidar to Inhibit P-glycoprotein at the Human Blood-Brain Barrier with (R)-11C-Verapamil and PET.
- Author
-
Wagner, Claudia C., Bauer, Martin, Karch, Rudolf, Feurstein, Thomas, Kopp, Stephan, Chiba, Peter, Kletter, Kurt, Löscher, Wolfgang, Müller, Markus, Zeitlinger, Markus, and Langer, Oliver
- Published
- 2009
- Full Text
- View/download PDF
10. Age dependency of cerebral P-gp function measured with ( R)-[11C]verapamil and PET.
- Author
-
Bauer, Martin, Karch, Rudolf, Neumann, Friederike, Abrahim, Aiman, Wagner, Claudia C., Kletter, Kurt, Müller, Markus, Zeitlinger, Markus, and Langer, Oliver
- Subjects
VERAPAMIL ,P-glycoprotein ,POSITRON emission tomography ,CEREBELLUM ,AMYGDALOID body - Abstract
The aim of this study was to assess the influence of age on the functional activity of the multidrug efflux transporter P-glycoprotein (P-gp) at the human blood-brain barrier. Seven young (mean age: 27 ± 4 years) and six elderly (mean age: 69 ± 9 years) healthy volunteers underwent dynamic ( R)-[
11 C]verapamil (VPM) positron emission tomography (PET) scans and arterial blood sampling. Parametric distribution volume (DV) images were generated using Logan linearisation, and age groups were compared with statistical parametric mapping (SPM). Brain regions that SPM analysis had shown to be most affected by age were analysed by a region of interest (ROI)-based approach using a maximum probability brain atlas, before and after partial volume correction (PVC). SPM analysis revealed significant clusters of DV increases in cerebellum, temporal and frontal lobe of elderly compared to younger subjects. In the ROI-based analysis, elderly subjects showed significant DV increases in amygdala (+30%), insula (+26%) and cerebellum (+25%) before PVC, and in insula (+33%) after PVC. Increased VPM DV values in the brains of elderly subjects suggest a decrease in cerebral P-gp function with increasing age. [ABSTRACT FROM AUTHOR]- Published
- 2009
- Full Text
- View/download PDF
11. Aggression is related to frontal serotonin-1A receptor distribution as revealed by PET in healthy subjects.
- Author
-
Witte, A. Veronica, Flöel, Agnes, Stein, Patrycja, Savli, Markus, Mien, Leonhard-Key, Wadsak, Wolfgang, Spindelegger, Christoph, Moser, Ulrike, Fink, Martin, Hahn, Andreas, Mitterhauser, Markus, Kletter, Kurt, Kasper, Siegfried, and Lanzenberger, Rupert
- Abstract
Objectives: Various studies indicate that serotonin regulates impulsivity and the inhibitory control of aggression. Aggression is also known to be modified by sex hormones, which exert influence on serotonergic neurotransmission. The present study aimed to elucidate potential interactions between human aggression, the inhibitory serotonergic 5-HT
1A receptor, and sex hormones. Experimental Design: Thirty-three healthy volunteers (16 women, aged 26.24 ± 5.5 yr) completed a validated questionnaire incorporating five dimensions of aggression. Subsequently, all subjects underwent positron emission tomography with the radioligand [carbonyl-11 C]WAY-100635 to quantify 5-HT1A binding potentials (BPND s) in the prefrontal cortex, limbic areas, and midbrain. Also, plasma levels of testosterone, 17ß-estradiol and sex hormone-binding globulin (SHBG) were measured. Relations between aggression scores, regional 5-HT1A BPND s, and hormone levels were analyzed using correlations, multivariate analyses of variance, and linear regressions. Principal Observations: Statistical analyses revealed higher 5-HT1A receptor BPND s in subjects exhibiting higher aggression scores in prefrontal (all P < 0.041) and anterior cingulate cortices ( P = 0.016). More aggressive subjects were also characterized by lower SHBG levels ( P = 0.015). Moreover, higher SHBG levels were associated with lower 5-HT1A BPND s in frontal ( P = 0.048) and cingulate cortices (all P < 0.013) and in the amygdala ( P = 0.03). Conclusions: The present study provides first-time evidence for a specific interrelation between the 5-HT1A receptor distribution, sex hormones, and aggression in humans. Our findings point to a reduced down-stream control due to higher amounts or activities of frontal 5-HT1A receptors in more aggressive subjects, which is presumably modulated by sex hormones. Hum Brain Mapp 30:2558-2570, 2009. © 2008 Wiley-Liss, Inc. [ABSTRACT FROM AUTHOR]- Published
- 2009
- Full Text
- View/download PDF
12. The serotonin-1A receptor distribution in healthy men and women measured by PET and [ carbonyl-11C]WAY-100635.
- Author
-
Stein, Patrycja, Savli, Markus, Wadsak, Wolfgang, Mitterhauser, Markus, Fink, Martin, Spindelegger, Christoph, Mien, Leonhard-Key, Moser, Ulrike, Dudczak, Robert, Kletter, Kurt, Kasper, Siegfried, and Lanzenberger, Rupert
- Subjects
SEROTONIN antagonists ,SEX factors in disease ,DEPRESSION in women ,DEPRESSION in men ,ANXIETY disorders ,POSITRON emission tomography ,HORMONES ,PSYCHOLOGY ,PHYSIOLOGY - Abstract
The higher prevalence rates of depression and anxiety disorders in women compared to men have been associated with sexual dimorphisms in the serotonergic system. The present positron emission tomography (PET) study investigated the influence of sex on the major inhibitory serotonergic receptor subtype, the serotonin-1A (5-HT
1A ) receptor. Sixteen healthy women and 16 healthy men were measured using PET and the highly specific radioligand [ carbonyl-11 C]WAY-100635. Effects of age or gonadal hormones were excluded by restricting the inclusion criteria to young adults and by controlling for menstrual cycle phase. The 5-HT1A receptor BPND was quantified using (1) the ‘gold standard’ manual delineation approach with ten regions of interest (ROIs) and (2) a newly developed delineation method using a PET template normalized to the Montreal Neurologic Institute space with 45 ROIs based on automated anatomical labeling. The 5-HT1A receptor BPND was found equally distributed in men and women applying both the manual delineation method and the automated delineation approach. Women had lower mean BPND values in every region investigated, with a borderline significant sex difference in the hypothalamus ( p = 0.012, uncorrected). There was a high intersubject variability of the 5-HT1A receptor BPND within both sexes compared to the small mean differences between men and women. To conclude, when measured in the follicular phase, women do not differ from men in the 5-HT1A receptor binding. To explain the higher prevalence of affective disorders in women, further studies are needed to evaluate the relationship between hormonal status and the 5-HT1A receptor expression. [ABSTRACT FROM AUTHOR]- Published
- 2008
- Full Text
- View/download PDF
13. Tariquidar-Induced P-Glycoprotein Inhibition at the Rat Blood--Brain Barrier Studied with (R)-11C-Verapamil and PET.
- Author
-
Bankstahl, Jens P., Kuntner, Claudia, Abrahim, Aiman, Karch, Rudolf, Stanek, Johann, Wanek, Thomas, Wadsak, Wolfgang, Kletter, Kurt, Müller, Markus, Löscher, Wolfgang, and Langer, Oliver
- Published
- 2008
- Full Text
- View/download PDF
14. Peripheral metabolism of ( R)-[11C]verapamil in epilepsy patients.
- Author
-
Abrahim, Aiman, Luurtsema, Gert, Bauer, Martin, Karch, Rudolf, Lubberink, Mark, Pataraia, Ekaterina, Joukhadar, Christian, Kletter, Kurt, Lammertsma, Adriaan A., Baumgartner, Christoph, Müller, Markus, and Langer, Oliver
- Subjects
POSITRON emission tomography ,VERAPAMIL ,METABOLISM ,PERIPHERAL circulation ,PEOPLE with epilepsy ,TEMPORAL lobe epilepsy - Abstract
( R)-[
11 C]verapamil is a new PET tracer for P-glycoprotein-mediated transport at the blood-brain barrier. For kinetic analysis of ( R)-[11 C]verapamil PET data the measurement of a metabolite-corrected arterial input function is required. The aim of this study was to assess peripheral ( R)-[11 C]verapamil metabolism in patients with temporal lobe epilepsy and compare these data with previously reported data from healthy volunteers. Arterial blood samples were collected from eight patients undergoing ( R)-[11 C]verapamil PET and selected samples were analysed for radiolabelled metabolites of ( R)-[11 C]verapamil by using an assay that measures polar N-demethylation metabolites by solid-phase extraction and lipophilic N-dealkylation metabolites by HPLC. Peripheral metabolism of ( R)-[11 C]verapamil was significantly faster in patients compared to healthy volunteers ( AUC of ( R)-[11 C]verapamil fraction in plasma: 29.4 ± 3.9 min for patients versus 40.8 ± 5.0 min for healthy volunteers; p < 0.0005, Student’s t-test), which resulted in lower ( R)-[11 C]verapamil plasma concentrations ( AUC of ( R)-[11 C]verapamil concentration, normalised to injected dose per body weight: 25.5 ± 2.1 min for patients and 30.5 ± 5.9 min for healthy volunteers; p = 0.038). Faster metabolism appeared to be mainly due to increased N-demethylation as the polar [11 C]metabolite fraction was up to two-fold greater in patients. Faster metabolism of ( R)-[11 C]verapamil in epilepsy patients may be caused by hepatic cytochrome P450 enzyme induction by antiepileptic drugs. Based on these data caution is warranted when using an averaged arterial input function derived from healthy volunteers for the analysis of patient data. Moreover, our data illustrate how antiepileptic drugs may decrease serum levels of concomitant medication, which may eventually lead to a loss of therapeutic efficacy. [ABSTRACT FROM AUTHOR]- Published
- 2008
- Full Text
- View/download PDF
15. Pharmacoresistance in Epilepsy: A Pilot PET Study with the P-Glycoprotein Substrate R-[11C]verapamil.
- Author
-
Langer, Oliver, Bauer, Martin, Hammers, Alexander, Karch, Rudolf, Pataraia, Ekaterina, Koepp, Matthias J., Abrahim, Aiman, Luurtsema, Gert, Brunner, Martin, Sunder-Plassmann, Raute, Zimprich, Friedrich, Joukhadar, Christian, Gentzsch, Stephan, Dudczak, Robert, Kletter, Kurt, Müller, Markus, and Baumgartner, Christoph
- Subjects
EPILEPSY ,SEIZURES (Medicine) ,PILOT projects ,P-glycoprotein ,VERAPAMIL ,CALCIUM antagonists - Abstract
Purpose and Methods: Regional overexpression of the multidrug transporter P-glycoprotein (P-gp) in epileptic brain tissue may lower target site concentrations of antiepileptic drugs and thus contribute to pharmacoresistance in epilepsy. We used the P-gp substrate R-[
11 C]verapamil and positron emission tomography (PET) to test for differences in P-gp activity between epileptogenic and nonepileptogenic brain regions of patients with drug-resistant unilateral temporal lobe epilepsy (n = 7). We compared R-[11 C]verapamil kinetics in homologous brain volumes of interest (VOIs) located ipsilateral and contralateral to the seizure focus. Results: Among different VOIs, radioactivity was highest in the choroid plexus. The hippocampal VOI could not be used for data analysis because it was contaminated by spill-in of radioactivity from the adjacent choroid plexus. In several other temporal lobe regions that are known to be involved in seizure generation and propagation ipsilateral influx rate constants K1 and efflux rate constants k2 of R-[11 C]verapamil were descriptively increased as compared to the contralateral side. Parameter asymmetries were most prominent in parahippocampal and ambient gyrus ( K1 , range: −3.8% to +22.3%; k2 , range: −2.3% to +43.9%), amygdala ( K1 , range: −20.6% to +31.3%; k2 , range: −18.0% to +38.9%), medial anterior temporal lobe ( K1 , range: −8.3% to +14.5%; k2 , range: −14.5% to +31.0%) and lateral anterior temporal lobe ( K1 , range: −20.7% to +16.8%; k2 , range: −24.4% to +22.6%). In contrast to temporal lobe VOIs, asymmetries were minimal in a region presumably not involved in epileptogenesis located outside the temporal lobe (superior parietal gyrus, K1 , range: −3.7% to +4.5%; k2 , range: −4.2% to +5.8%). In 5 of 7 patients, ipsilateral efflux ( k2 ) increases were more pronounced than ipsilateral influx ( K1 ) increases, which resulted in ipsilateral reductions (10%–26%) of R-[11 C]verapamil distribution volumes (DV). However, for none of the examined brain regions, any of the differences in K1 , k2 and DV between the epileptogenic and the nonepileptogenic hemisphere reached statistical significance (p > 0.05, Wilcoxon matched pairs test). Conclusions: Even though we failed to detect statistically significant differences in R-[11 C]verapamil model parameters between epileptogenic and nonepileptogenic brain regions, it cannot be excluded from our pilot data in a small sample size of patients that regionally enhanced P-gp activity might contribute to drug resistance in some patients with temporal lobe epilepsy. [ABSTRACT FROM AUTHOR]- Published
- 2007
- Full Text
- View/download PDF
16. Typical Chest Pain and Normal Coronary Angiogram: Cardiac Risk Factor Analysis Versus PET for Detection of Microvascular Disease.
- Author
-
Graf, Senta, Khorsand, Aliasghar, Gwechenberger, Marianne, Novotny, Clemens, Kletter, Kurt, Sochor, Heinz, Pirich, Christian, Maurer, Gerald, Porenta, Gerold, and Zehetgruber, Manfred
- Published
- 2007
17. Comparison of 11C-acetate positron emission tomography and 67Gallium citrate scintigraphy in patients with hepatocellular carcinoma.
- Author
-
Li, Shuren, Beheshti, Mohsen, Peck-Radosavljevic, Markus, Oezer, Simon, Grumbeck, Elke, Schmid, Monika, Hamilton, Gerhard, Kapiotis, Stylianos, Dudczak, Robert, and Kletter, Kurt
- Subjects
DIAGNOSTIC imaging ,MEDICAL imaging systems ,LIVER cancer ,POSITRON emission tomography ,CANCER patients ,PHOTON emission ,LYMPH nodes ,METASTASIS - Abstract
Nuclear imaging may have an increasing role in the diagnosis of hepatocellular carcinoma (HCC). The aim of this study was to compare prospectively the Gallium-67 citrate (
67 Ga) scintigraphy results with those obtained by positron emission tomography (PET) using11 C-acetate in patients with HCC. Methods: We prospectively analysed 21 patients (mean age, 64±11 years) with histopathologically verified HCC undergoing11 C-acetate PET and67 Ga scintigraphy.67 Ga scans were not performed in three of these 21 patients due to the exacerbation of the disease. Whole-body11 C-acetate PET were performed following intravenous injection of 850 MBq of11 C-acetate. For67 Ga scintigraphy, whole-body, planar and single photon emission computed tomography imaging acquisitions were performed after intravenous application of a mean dose of 189 MBq67 Ga. Results:67 Ga scintigraphy found abnormalities only in 10 of 18 patients (56%) and detected 22 of 46 clinically involved sites (48%); it was false-positive in two patients.11 C-acetate PET found abnormalities in 14 of 18 patients (78%) and detected 36 of 46 clinical lesions (78%); it was false-positive in one patients. In one patient with left supraclavicular lymph node metastases, neither the67 Ga scintigraphy nor the conventional computed tomography have shown the lesions, which were clearly demonstrated by the11 C-acetate PET. Conclusion: Our results indicate significantly higher sensitivity and specificity of11 C-acetate PET than67 Ga scan in detection of HCC lesions. This study suggests that imaging with11 C-acetate PET might play a potential role in the diagnostic workup of patients with HCC. [ABSTRACT FROM AUTHOR]- Published
- 2006
- Full Text
- View/download PDF
18. A positron emission tomography microdosing study with a potential antiamyloid drug in healthy volunteers and patients with Alzheimer's disease*.
- Author
-
Bauer, Martin, Langer, Oliver, Dal-Bianco, Peter, Karch, Rudolf, Brunner, Martin, Abrahim, Aiman, Lanzenberger, Rupert, Hofmann, Andrea, Joukhadar, Christian, Carminati, Paolo, Ghirardi, Orlando, Piovesan, Paola, Forloni, Gianluigi, Corrado, Mario E., Lods, Nadège, Dudczak, Robert, Auff, Eduard, Kletter, Kurt, and Müller, Markus
- Subjects
POSITRON emission tomography ,DRUG dosage ,PHARMACODYNAMICS ,PHARMACOKINETICS ,THERAPEUTICS - Abstract
This work describes a microdosing study with an investigational, carbon 11–labeled antiamyloid drug, 1,1′-methylene-di-(2-naphthol) (ST1859), and positron emission tomography (PET) in healthy volunteers (n = 3) and patients with Alzheimer's disease (n = 6). The study aimed to assess the distribution and local tissue pharmacokinetics of the study drug in its target organ, the human brain. Before PET studies were performed in humans, the toxicologic characteristics of ST1859 were investigated by an extended single-dose toxicity study according to guidelines of the Food and Drug Administration and European Medicines Agency, which are relevant for clinical trials with a single microdose. After intravenous bolus injection of 341 ± 21 MBq [
11 C]ST1859 (containing <11.4 nmol of unlabeled ST1859), peripheral metabolism was rapid, with less than 20% of total plasma radioactivity being in the form of unchanged parent drug at 10 minutes after administration. In both the control and patient groups, uptake of radioactivity into the brain was relatively fast (time to reach maximum concentration, 9-17 minutes) and pronounced (maximum concentration [standardized uptake value], 1.3-2.2). In both healthy volunteers and patients, there was a rather uniform distribution of radioactivity in the brain, including both amyloid-beta–rich and –poor regions, with slow washout of radioactivity (half-life, 82-185 minutes). In conclusion, these data provide important information on the blood-brain barrier penetration and metabolism of an investigational antiamyloid drug and suggest that the PET microdosing approach is a useful method to describe the target-organ pharmacokinetics of radiolabeled drugs in humans.Clinical Pharmacology & Therapeutics (2006) 80, 216–227; doi: 10.1016/j.clpt.2006.05.007 [ABSTRACT FROM AUTHOR]- Published
- 2006
- Full Text
- View/download PDF
19. [18F]FETO: metabolic considerations.
- Author
-
Ettlinger, Dagmar E., Wadsak, Wolfgang, Mien, Leonhard-Key, Machek, Michael, Wabnegger, Leila, Rendl, Gundula, Karanikas, Georgios, Viernstein, Helmut, Kletter, Kurt, Dudczak, Robert, and Mitterhauser, Markus
- Subjects
ENZYMES ,BIOSYNTHESIS ,STEROID hormones ,ADRENAL cortex ,ETOMIDATE - Abstract
Purpose: 11β-Hydroxylase is a key enzyme in the biosynthesis of adrenocortical steroid hormones and is a suitable target for the imaging of the adrenal cortex. [
11 C]Metomidate (MTO), [11 C]etomidate (ETO) and desethyl-[18 F]fluoroethyl-etomidate (FETO) are potent inhibitors of this enzyme and are used for PET imaging of adrenocortical pathologies. The aims of this study were (1) to evaluate and compare the metabolic stability of MTO, ETO and FETO against esterases and (2) to investigate the metabolic pattern of FETO in vivo. Methods: In vitro assays were performed using different concentrations of MTO, ETO and FETO with constant concentrations of carboxylesterase. Human in vivo studies were performed with human blood samples drawn from the cubital vein. After sample clean-up, the serum was analysed by HPLC methods. Results: In vitro assays showed Michaelis-Menten constants of 115.1 µmol for FETO, 162.0 µmol for MTO and 168.6 µmol for ETO. Limiting velocities were 1.54 µmol/min (FETO), 1.47 µmol/min (MTO) and 1.35 µmol/min (ETO). This implies insignificantly decreased esterase stability of FETO compared with MTO and ETO. In vivo investigations showed a rapid metabolisation of FETO within the first 10 min (2 min: 91.41%±6.44%, n=6; 10 min: 23.78%±5.54%, n=4) followed by a smooth decrease in FETO from 20 to 90 min (20 min: 11.23%±3.79% n=4; 90 min: 3.68%±3.65%, n=4). Recovery rate was 61.43% ±3.19% (n=12). Conclusion: In vitro experiments demonstrated that FETO stability against esterases is comparable to that of ETO and MTO. The metabolic profile showed that FETO kinetics in humans are fast. [ABSTRACT FROM AUTHOR]- Published
- 2006
- Full Text
- View/download PDF
20. [18F]FETO for adrenocortical PET imaging: a pilot study in healthy volunteers.
- Author
-
Wadsak, Wolfgang, Mitterhauser, Markus, Rendl, Gundula, Schuetz, Matthias, Mien, Leonhard Key, Ettlinger, Dagmar E., Dudczak, Robert, Kletter, Kurt, and Karanikas, Georgios
- Subjects
POSITRON emission tomography ,DIAGNOSTIC imaging ,ADRENAL cortex ,ADRENAL glands ,PANCREAS - Abstract
Purpose: Functional imaging of the adrenal cortex by means of PET may play an important clinical role. Recently, we presented the synthesis and first evaluation of a novel 11β-hydroxylase inhibitor, [
18 F] FETO, in rats displaying high tracer accumulation in the adrenals. In this study, we aimed to investigate for the first time the potency of [18 F]FETO as a PET tracer for the adrenal cortex in humans. Methods: An average preparation yielded 1-2 GBq of [18 F]FETO ready to use. Ten healthy volunteers aged 24-57 years (five male and five female) were included in the study. After i.v. administration of 365 MBq [18 F] FETO (246-391 MBq), dynamic images were acquired in 2D standard mode in 14 frames over 45 min. Afterwards, whole-body scanning was performed. In addition to visual interpretation, semi-quantitative analysis using standardised uptake values (SUVs) was conducted. Results: [18 F]FETO distribution was similar in all scanned volunteers. Visually, pronounced accumulation of [18 F] FETO was found in the adrenals, whereas moderate uptake was observed—at least in some of the subjects—for liver, renal calices, gallbladder, stomach walls and pancreas. Kidney and bowels showed only faint uptake. Median SUVs for the right and left adrenal glands were 15.6 (10.0-28.6) and 15.7 (10.3-35.9), respectively. The reference tissue (liver) displayed a median SUV of 2.5 (2.2-4.6). Conclusion: [18 F]FETO is a valuable tracer for adrenocortical PET imaging, combining the longer half-life of18 F with a high 11β-hydroxylase selectivity. In accordance with our findings in rats, FETO PET revealed very high accumulation in the adrenal glands in healthy volunteers. [ABSTRACT FROM AUTHOR]- Published
- 2006
- Full Text
- View/download PDF
21. Uptake of bone-seekers is solely associated with mineralisation! A study with 99mTc-MDP, 153Sm-EDTMP and 18F-fluoride on osteoblasts.
- Author
-
Toegel, Stefan, Hoffmann, Oskar, Wadsak, Wolfgang, Ettlinger, Dagmar, Mien, Leonhard-Key, Wiesner, Karoline, Nguemo, Joseph, Viernstein, Helmut, Kletter, Kurt, Dudczak, Robert, and Mitterhauser, Markus
- Subjects
BIOMINERALIZATION ,FLUORIDES ,RADIOACTIVE tracers ,NUCLEAR medicine ,CELL culture - Abstract
Purpose: Although polyphosphonates (PPs) were introduced as bone imaging agents in nuclear medicine in the early 1970s, the mechanisms involved in their uptake still remain unclear. Suggested mechanisms range from mineral adsorption with disputed binding to the organic phase, over incorporation into the mineralisation process to a combination of both mechanisms. Thus, our investigations aimed to: (1) evaluate adsorption parameters of
99m Tc-MDP,153 Sm-EDTMP and18 F-fluoride on mineralising osteoblast cultures, (2) correlate the radiotracer binding measured in the cell cultures with binding values from our previously presented mineral model and (3) compare binding with cell number. Methods: Primary osteoblasts were obtained by sequential digestion of foetal mice calvariae. The cells were incubated with 0.3 µmol of radiolabelled PPs or 25 MBq18 F-fluoride for 120 min. Gamma signals from labelled samples were detected with a Millennium Hawkeye SPECT camera or with a dedicated Advance full-ring PET scanner and the binding percentages were calculated. Results: From days 8 to 15 of culture, the percent binding of all evaluated tracers increased significantly, whereas the protein concentration showed insignificant changes. Additional comparisons of the binding values with our recently published pre-vivo model revealed remarkable agreement, suggesting solely bone-forming minerals to be responsible for radiotracer binding. Conclusion: This study provides evidence that binding of the evaluated radiotracers is not associated with osteoblast numbers but only with the concentration of bone-forming minerals. The presented correlations substantiate our recently presented pre-vivo model for the evaluation of bone-seekers: mechanisms associated with the uptake of bone-seekers are irreversible and mineral-associated processes. [ABSTRACT FROM AUTHOR]- Published
- 2006
- Full Text
- View/download PDF
22. Synthesis of fluorine-18-labelled 5- and 6-fluoro-2-pyridinamine.
- Author
-
Abrahim, Aiman, Angelberger, Peter, Kletter, Kurt, Müller, Markus, Joukhadar, Christian, Erker, Thomas, and Langer, Oliver
- Published
- 2006
- Full Text
- View/download PDF
23. Gated Cardiac 13N-NH3 PET for Assessment of Left Ventricular Volumes, Mass, and Ejection Fraction: Comparison with Electrocardiography- Gated 18F-FDG PET.
- Author
-
Khorsand, Aliasghar, Graf, Senta, Eidherr, Harald, Wadsak, Wolfgang, Kletter, Kurt, Sochor, Heinz, Schuster, Ernst, and Porenta, Gerold
- Published
- 2005
24. Combined PET and Microdialysis for In Vivo Assessment of Intracellular Drug Pharmacokinetics in Humans.
- Author
-
Langer, Oliver, Karch, Rudolf, Müller, Ulrich, Dobrozemsky, Georg, Abrahim, Aiman, Zeitlinger, Markus, Lackner, Edith, Joukhadar, Christian, Dudczak, Robert, Kletter, Kurt, Mu¨ller, Markus, and Brunner, Martin
- Published
- 2005
25. Relation of anti-TPO autoantibody titre and T-lymphocyte cytokine production patterns in Hashimoto's thyroiditis.
- Author
-
Karanikas, Georgios, Schuetz, Matthias, Wahl, Katharina, Paul, Matthias, Kontur, Sylvester, Pietschmann, Peter, Kletter, Kurt, Dudczak, Robert, and Willheim, Martin
- Subjects
AUTOIMMUNE thyroiditis ,CYTOKINES ,T cells ,AUTOANTIBODIES ,SERUM ,INTERFERONS - Abstract
Cytokines produced by cytotoxic T cells or autoantibodies lead to thyroid cell damage and/or cell death in Hashimoto's thyroiditis (HT). Anti-TPO autoantibodies (TPOAb) are the most frequently represented autoantibodies in the sera of patients with HT. Data describing the quantitative correlation between TPOAb titre and cytokine pattern are missing so far. To our knowledge this is the first study systematically evaluating the correlation of possible parameters of disease activity such as changes in CD4 and CD8 T-cell cytokine production and of TPOAb titre. Twenty-four consecutive patients (aged 29–58) with verified HT under levothyroxine therapy were included in the present study. The patients were divided into two groups. Group I: 12 HT patients with a high TPOAb titre (> 1000 U/ml), group II: 12 HT patients with a low TPOAb titre (< 100 U/ml). All patients underwent intracellular cytokine detection in CD4 and CD8 T cells of peripheral blood mononuclear cells (PBMC) by flow cytometry. Twelve healthy volunteers matched in sex and age consisted the control group (group III). T cells from patients with a high TPOAb titre (group I) had significantly higher percentages of cells producing IFN-γ compared to healthy donors (group III). A detailed analysis of cytokine production patterns revealed that this was accompanied by an increased frequency of single IFN-γ positive cells, i.e. cells not expressing other cytokines tested, such as IL-2, IL-4, IL-5, IL-6, IL-10, IL-13 or TNF-β. Similarly, patients in group I also showed higher percentages of TNF-α positive cells than healthy donors (group III). In this case, cells expressing TNF-α alone as well as cells coexpressing TNF-α and IFN-γ were found at significantly higher frequencies. On the other hand, cytokine production patterns of patients with a low TPOAb titre (group II) showed significant difference neither to patients of group I nor to healthy donors (group III). Taken together, we were able for the first time to demonstrate that high TPOAb titre correlates with increased frequencies of T cells producing Th/Tc1 cytokines, probably responsible for thyroid cell damage and/or death in Hashimoto's thyroiditis. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
26. Influence of functional haplotypes in the drug transporter gene ABCB1 on central nervous system drug distribution in humans
- Author
-
Brunner, Martin, Langer, Oliver, Sunder-Plassmann, Raute, Dobrozemsky, Georg, Müller, Ulrich, Wadsak, Wolfgang, Krcal, Andreas, Karch, Rudolf, Mannhalter, Christine, Dudczak, Robert, Kletter, Kurt, Steiner, Ilka, Baumgartner, Christoph, and Müller, Markus
- Subjects
CALCIUM antagonists ,CARDIOVASCULAR agents ,POSITRON emission tomography ,GENETIC polymorphisms ,P-glycoprotein - Abstract
Background and Objective: Single nucleotide polymorphisms in the human multidrug-resistance gene ABCB1 have been reported to be associated with altered expression and function of P-glycoprotein, an efflux transporter, expressed at the blood-brain barrier. To test whether certain ABCB1 haplotypes contribute to interindividual differences in central nervous system drug distribution, brain distribution of a model P-glycoprotein substrate, the calcium channel inhibitor verapamil, was measured by positron emission tomography (PET) in 2 groups of healthy volunteers. Methods: Ten homozygous carriers (cases) of the TTT haplotype (3435T, 1236T, and 2677T) and 10 controls homozygous for the wild-type CGC haplotype (3435C, 2677G, and 1236C) were administered a mean intravenous bolus of 412 ± 114 MBq carbon 11-labeled verapamil containing less than 15 nmol of unlabeled verapamil. PET imaging of brain tissue and venous blood sampling were performed for 1 hour after dosing. Results: As a measure of brain penetration, the ratio of PET area under the time-radioactivity curve (AUC) to plasma AUC was calculated from time-radioactivity curves, with a mean ratio of 1.1 ± 0.3 (SD) (95% confidence interval, 0.9–1.3) for cases and 1.1 ± 0.2 (95% confidence interval, 0.9–1.2) for controls, respectively (P = .96). Mean brain AUC values were 31.2 ± 3.9 and 35.7 ± 5.7 for the TTT and CGC haplotype, respectively (P = .11). Plasma AUCs were not significantly different. Conclusion: No difference in the brain distribution of [
11 C]verapamil could be detected in healthy volunteers differing in ABCB1 haplotypes. [Copyright &y& Elsevier]- Published
- 2005
- Full Text
- View/download PDF
27. Assessment of myocardial perfusion by dynamic N-13 ammonia PET imaging: Comparison of 2 tracer kinetic models
- Author
-
Khorsand, Aliasghar, Graf, Senta, Pirich, Christian, Muzik, Otto, Kletter, Kurt, Dudczak, Robert, Maurer, Gerald, Sochor, Heinz, Schuster, Ernst, and Porenta, Gerold
- Subjects
POSITRON emission tomography ,DIAGNOSTIC imaging ,MEDICAL radiography ,BLOOD circulation - Abstract
Background: Measurement of myocardial blood flow (MBF) by dynamic nitrogen 13 ammonia (NH
3 ) positron emission tomography (PET) uses tracer kinetic modeling to analyze time-activity curves. We compared 2 commonly used models with 2 compartments (2C) and 3 compartments (3C) for quantification of MBF and coronary flow reserve (CFR). Methods and Results: Seventy-seven patients underwent NH3 PET at rest and during hyperemia. Time-activity curves for blood pool and myocardial segments were obtained from short-axis images of dynamic sequences. Model fitting of the 2C and 3C models was performed to estimate regional MBF. MBF values calculated by 2C and 3C models were 0.98 ± 0.31 mL·min−1 ·g−1 and 1.11 ± 0.37 mL·min−1 ·g−1 , respectively, at rest (P < .0001) and 2.79 ± 1.18 mL·min−1 ·g−1 and 2.46 ± 1.02 mL·min−1 ·g−1 , respectively, during hyperemia (P < .01), resulting in a CFR of 3.02 ± 1.31 and 2.39 ± 1.15 (P < .0001), respectively. Significant correlation was observed between the 2 models for calculation of resting MBF (r = 0.78), hyperemic MBF (r = 0.68), and CFR (r = 0.68). Conclusion: Measurements of MBF and CFR by 2C and 3C models are significantly related. However, quantification of MBF and CFR significantly differs between the methods. This difference needs to be considered when normal values are established or when measurements obtained with different methods need to be compared. [Copyright &y& Elsevier]- Published
- 2005
- Full Text
- View/download PDF
28. Synthesis of 1,1′ [11C]-methylene-di-(2-naphthol) ([11C]ST1859) for PET studies in humans.
- Author
-
Langer, Oliver, Krcal, Andreas, Schmid, Alexander, Abrahim, Aiman, Minetti, Patrizia, Celona, Diana, Roeda, Dirk, Dollé, Frédéric, Kletter, Kurt, and Müller, Markus
- Published
- 2005
- Full Text
- View/download PDF
29. In vitro and in vivo evaluation of [18F]ciprofloxacin for the imaging of bacterial infections with PET.
- Author
-
Langer, Oliver, Brunner, Martin, Zeitlinger, Markus, Ziegler, Sophie, Müller, Ulrich, Dobrozemsky, Georg, Lackner, Edith, Joukhadar, Christian, Mitterhauser, Markus, Wadsak, Wolfgang, Minar, Erich, Dudczak, Robert, Kletter, Kurt, and Müller, Markus
- Subjects
ANTIBIOTICS ,CIPROFLOXACIN ,QUINOLONE antibacterial agents ,BACTERIAL diseases ,ESCHERICHIA coli diseases ,RADIOACTIVITY - Abstract
Purpose: The suitability of the
18 F-labelled fluoroquinolone antibiotic ciprofloxacin ([18 F]ciprofloxacin) for imaging of bacterial infections with positron emission tomography (PET) was assessed in vitro and in vivo. Methods: For the in vitro experiments, suspensions of various E. coli strains were incubated with different concentrations of [18 F]ciprofloxacin (0.01-5.0 μg/ml) and radioactivity retention was measured in a gamma counter. For the in vivo experiments, 725 ± 9 MBq [18 F]ciprofloxacin was injected intravenously into four patients with microbiologically proven bacterial soft tissue infections of the lower extremities and time-radioactivity curves were recorded in infected and uninfected tissue for 5 h after tracer injection. Results: Binding of [18 F]ciprofloxacin to bacterial cells was rapid, non-saturable and readily reversible. Moreover, bacterial binding of the agent was similar in ciprofloxacin-resistant and ciprofloxacin-susceptible clinical isolates. These findings suggest that non-specific binding rather than specific binding to bacterial type II topoisomerase enzymes is the predominant mechanism of bacterial retention of the radiotracer. PET studies in the four patients with microbiologically proven bacterial soft tissue infections demonstrated locally increased radioactivity uptake in infected tissue, with peak ratios between infected and uninfected tissue ranging from 1.8 to 5.5. Radioactivity was not retained in infected tissue and appeared to wash out with a similar elimination half-life as in uninfected tissue, suggesting that the kinetics of [18 F]ciprofloxacin in infected tissue are governed by increased blood flow and vascular permeability due to local infection rather than by a binding process. Conclusion: Taken together, our results indicate that [18 F]ciprofloxacin is not suited as a bacteria-specific infection imaging agent for PET. [ABSTRACT FROM AUTHOR]- Published
- 2005
- Full Text
- View/download PDF
30. Synthesis and biodistribution of [18F]FE@CIT, a new potential tracer for the dopamine transporter.
- Author
-
Mitterhauser, Markus, Wadsak, Wolfgang, Mien, Leonhard-Key, Hoepping, Alexander, Viernstein, Helmut, Dudczak, Robert, and Kletter, Kurt
- Abstract
In the last decade radiolabeled tropane analogs based on β-CIT have proven indispensable for the imaging of the dopamine transporter. However, further improvements in their pharmacodynamic and pharmacokinetic features are desirable. An important improvement, yielding in higher affinity to the dopamine transporter (DAT) vs. serotonin transporter (SERT), can be achieved by a simple replacement of the carboxylic methyl ester group in β-CIT by a fluoroethyl ester. The preparation and ex vivo evaluation of this new β-CIT-analog ([
18 F]FE@CIT) is presented here. Precursor and standard were prepared from β-CIT and analyzed by spectroscopic methods. Yields of precursor and standard preparation were 61% and 42%, respectively. [18 F]FE@CIT was prepared by distillation of [18 F]bromofluoroethane ([18 F]BFE) and reaction with (1R-2-exo-3-exo)8-methyl-3-(4-iodo-phenyl)-8-azabicyclo[3.2.1] octane-2-carboxylic acid. After 10 min at 150°C the product was purified using a C-18 SepPak. The radiosynthesis evinced radiochemical yields of >90% (based on [18 F]BFE), the specific radioactivity was >416 GBq/μmol. An average 30 μAh cyclotron irradiation yielded more than 2.5 GBq [18 F]FE@CIT. For the ex vivo bioevaluation, 20 male Sprague-Dawley rats were sacrificed at 5, 15, 30, 60, and 120 min after injection. Organs were removed, weighed, and counted. For autoradiographic experiments, transverse brain slices of about 100 μm were prepared. The ex vivo evaluation showed highest brain uptake in striatal regions, followed by thalamus and cerebellum. The highest striatum to cerebellum ratio was 3.73 and the highest thalamus to cerebellum ratio was 1.65. Autoradiographic images showed a good and differentiated uptake in striatal regions with a good target-to-background ratio. Synapse 55:73-79, 2005. © 2004 Wiley-Liss, Inc. [ABSTRACT FROM AUTHOR]- Published
- 2005
- Full Text
- View/download PDF
31. Electromechanical Properties of Perfusion/ Metabolism Mismatch: Comparison of Nonfluoroscopic Electroanatomic Mapping with 18F-FDG PET.
- Author
-
Graf, Senta, Gyöngyösi, Mariann, Khorsand, Aliasghar, Nekolla, Stephan G., Pirich, Christian, Kletter, Kurt, Dudczak, Robert, Glogar, Dietmar, Porenta, Gerold, and Sochor, Heinz
- Published
- 2004
32. Positron emission tomography imaging of adrenal masses: 18F-fluorodeoxyglucose and the 11β-hydroxylase tracer 11C-metomidate.
- Author
-
Zettinig, Georg, Mitterhauser, Markus, Wadsak, Wolfgang, Becherer, Alexander, Pirich, Christian, Vierhapper, Heinrich, Niederle, Bruno, Dudczak, Robert, and Kletter, Kurt
- Subjects
POSITRON emission tomography ,ADRENAL cortex ,HYPERADRENOCORTICISM ,RENAL cancer ,MEDICAL imaging systems ,PRECANCEROUS conditions - Abstract
Purpose.
11 C-metomidate (MTO), a marker of 11β-hydroxylase, has been suggested as a novel positron emission tomography (PET) tracer for adrenocortical imaging. Up to now, experience with this very new tracer is limited. The aims of this study were (1) to evaluate this novel tracer, (2) to point out possible advantages in comparison with18 F-fluorodeoxyglucose (FDG) and (3) to investigate in vivo the expression of 11β-hydroxylase in patients with primary aldosteronism. Methods. Sixteen patients with adrenal masses were investigated using both MTO and FDG PET imaging. All patients except one were operated on. Five patients had non-functioning adrenal masses, while 11 had functioning tumours(Cushing’s syndrome, n=4; Conn’s syndrome, n=5; phaeochromocytoma, n=2). Thirteen patients had benign disease, whereas in three cases the adrenal mass was malignant (adrenocortical cancer, n=1; malignant phaeochromocytoma, n=1; adrenal metastasis of renal cancer, n=1). Results. MTO imaging clearly distinguished cortical from non-cortical adrenal masses (median standardised uptake values of 18.6 and 1.9, respectively, p<0.01). MTO uptake was slightly lower in patients with Cushing’s syndrome than in those with Conn’s syndrome, but the difference did not reach statistical significance. The expression of 11β-hydroxylase was not suppressed in the contralateral gland of patients with Conn’s syndrome, whereas in Cushing’s syndrome this was clearly the case. The single patient with adrenocortical carcinoma had MTO uptake in the lower range. Conclusion. MTO could not definitely distinguish between benign and malignant disease. FDG PET, however, identified clearly all three study patients with malignant adrenal lesions. We conclude: (1) MTO is an excellent imaging tool to distinguish adrenocortical and non-cortical lesions; (2) the in vivo expression of 11β-hydroxylase is lower in Cushing’s syndrome than in Conn’s syndrome, and there is no suppression of the contralateral gland in primary aldosteronism; (3) for the purpose of discriminating between benign and malignant lesions, FDG is the tracer of choice. [ABSTRACT FROM AUTHOR]- Published
- 2004
- Full Text
- View/download PDF
33. Imaging of Advanced Neuroendocrine Tumors with 18F-FDOPA PET.
- Author
-
Becherer, Alexander, Szabó, Monica, Karanikas, Georgios, Wunderbaldinger, Patrick, Angelberger, Peter, Raderer, Markus, Kurtaran, Amir, Dudczak, Robert, and Kletter, Kurt
- Published
- 2004
34. Isotopic Renal Function Studies in Severe Hypothyroidism and after Thyroid Hormone Replacement Therapy.
- Author
-
Karanikas, Georgios, Schütz, Matthias, Szabo, Monica, Becherer, Alexander, Wiesner, Karoline, Dudczak, Robert, and Kletter, Kurt
- Published
- 2004
- Full Text
- View/download PDF
35. Brain tumour imaging with PET: a comparison between [[sup 18]F]fluorodopa and [[sup 11]C]methionine.
- Author
-
Becherer, Alexander, Karanikas, Georgios, Szabó, Monica, Zetiinig, Georg, Asenbaum, Susanne, Marosi, Christine, Henk, Christine, Wunderbaldinger, Patrick, Czech, Thomas, Wadsak, Wolfgang, and Kletter, Kurt
- Subjects
AMINO acids ,BRAIN tumors ,FLUORINE ,POSITRON emission tomography ,CYCLOTRONS ,PHENYLALANINE - Abstract
Imaging of amino acid transport in brain tumours is more sensitive than fluorine-18 2-fluoro-deoxyglucose positron emission tomography (PET). The most frequently used tracer in this field is carbon-11 methionine (MET), which is unavailable for PET centres without a cyclotron because of its short half-life. The purpose of this study was to evaluate the performance of 3,4-dihydroxy-6-[[sup 18]F]fluoro-phenylalanine (FDOPA) in this setting, in comparison with MET. Twenty patients with known supratentorial brain lesions were referred for PET scans with FDOPA and MET. The diagnoses were 18 primary brain tumours, one metastasis and one non-neoplastic cerebral lesion. All 20 patients underwent PET with FDOPA (100 MBq, 20 min p.i.), and 19 of them also had PET scans with MET (800 MBq, 20 min p.i.). In all but one patient a histological diagnosis was available. In 15 subjects, histology was known from previous surgical interventions; in five of these patients, as well as in four previously untreated patients, histology was obtained after PET. In one untreated patient, confirmation of PET was possible solely by correlation with MRI; a histological diagnosis became available 10 months later. MET and FDOPA images matched in all patients and showed all lesions as hot spots with higher uptake than in the contralateral brain. Standardised uptake value ratios, tumour/contralateral side (mean±SD), were 2.05±0.91 for MET and 2.04±0.53 for FDOPA (NS). The benign lesion, which biopsy revealed to be a focal demyelination, was false positive, showing increased uptake of MET and FDOPA. We conclude that FDOPA is accurate as a surrogate for MET in imaging amino acid transport in malignant cerebral lesions for the purpose of visualisation of vital tumour tissue. It combines the good physical properties of [sup 18]F with the pharmacological properties of MET and might therefore be a valuable PET radiopharmaceutical in brain tumour imaging. [ABSTRACT FROM AUTHOR]
- Published
- 2003
- Full Text
- View/download PDF
36. Model-Based Analysis of Electrocardiography-Gated Cardiac 18F-FDG PET Images to Assess Left Ventricular Geometry and Contractile Function.
- Author
-
Khorsand, Aliasghar, Graf, Senta, Frank, Herbert, Kletter, Kurt, Sochor, Heinz, Maurer, Gerald, Schuster, Ernst, Globits, Sebastian, Dudczak, Robert, and Porenta, Gerold
- Published
- 2003
37. Hybrid Imaging bei endokrinen Erkrankungen: neue Perspektiven.
- Author
-
Kainberger, Franz, Kurtaran, Amir, Kienast, Oskar, Dobrozemsky, Georg, Czerny, Christian, and Kletter, Kurt
- Abstract
Copyright of Wiener Klinische Wochenschrift is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2003
38. In vivo and in vitro evaluation of [18 F ]FETO with respect to the adrenocortical and GABAergic system in rats.
- Author
-
Mitterhauser, Markus, Wadsak, Wolfgang, Wannegger, Leila, Siegharf, Werner, Viernstein, Helmut, Kletter, Kurt, and Dudczak, Robert
- Subjects
HYDROCORTISONE ,NUCLEAR medicine ,LABORATORY rats ,POSITRON emission tomography - Abstract
11β-Hydroxylase (CYP11B1, P450[sub11β]) plays an important role in the biosynthesis of cortisol and aldosterone and has been shown to be a good target for the in vivo imaging of adrenocortical incidentalomas in nuclear medicine. [[sup11]C]Metomidate (MTO), a potent inhibitor of this enzyme, is used for positron emission tomography (PET) imaging of adrenocortical pathology. The synthesis of (R)-1-(1-phenylethyl)-1H-imidazole-5-carboxylic acid 2-[[sup18]F]fluoroethylester (FETO), a close analogue to MTO and etomidate (ETO), has been presented recently, and the present investigation aimed to characterise the in vivo distribution of FETO. Since ETO is a well-known anaesthetic drug acting via the GABAergic system, the interaction of FETO with GABA[subA] receptors was also evaluated. Eighteen male Sprague-Dawley rats were injected with 1.73–3.06 MBq of FETO into a tail vein after venodilatation in a 40°C water bath. Rats were sacrificed by exsanguination from the abdominal aorta under deep ether anaesthesia after 10 (n=6), 30 (n=6) or 60 min (n=6); organs were removed, weighed and counted. For binding experiments, rat cerebellar membranes were incubated for 90 min at 4°C in TC-50 buffer, 150 mM NaCl and 2 nM of [³H]flunitrazepam in the absence or presence of 10 μM diazepam or various concentrations of ETO, MTO and FETO. In vivo evaluation evinced very high uptake in the adrenal glands (7.52%±1.19% ID/g at 30 min), followed by lung (1.18%±0.19% ID/g, 10 min), liver (0.59%±0.13% ID/g, 10 min) and duodenum (0.7%±0.29% ID/g, 60 min). No defluorination nor fluoroethyl-ester cleavage was observed. When brain re- gions were compared with the thalamus (the reference region), highest relative uptake was seen in the cortex (2.34), followed by “ rest brain” (2.13) and cerebellum (1.96). FETO and ETO were able to increase the binding of [³H]flunitrazepam with similar potencies and to a comparable extent. It is concluded that FETO shows characteristics suitable for the imaging of adrenocortical pathology with PET. Binding experiments on GABA receptors demonstrate a comparable effect of FETO and ETO. Hence, FETO possibly could also be used to elucidate the function, dynamics and kinetics of narcotic drugs with PET. [ABSTRACT FROM AUTHOR]
- Published
- 2003
- Full Text
- View/download PDF
39. [sup 18] F-Fluorodeoxyglucose Positron Emission Tomography ([sup 18] F-FDG-PET) for Staging and Follow-Up of Marginal Zone B-Cell Lymphoma.
- Author
-
Hoffmann, Martha, Kletter, Kurt, Becherer, Alexander, Jäger, Ulrich, Chott, Andreas, and Raderer, Markus
- Subjects
B cells ,LYMPHOMAS ,LYMPHOID tissue ,POSITRON emission tomography ,PATIENTS ,DISEASES - Abstract
Objective: According to recent reports, nodal marginal zone lymphoma (MZL) appears to be a distinctive lymphoma entity rather than a more advanced stage of extranodal MZL of mucosa-associated lymphoid tissue (MALT). We have therefore retrospectively evaluated all patients diagnosed with nodal or extranodal MZL who have been referred to our unit for imaging using [sup 18] F-fluorodeoxyglucose positron emission tomography ([sup 18] F-FDG-PET). Patients and Methods: A total of 21 patients with a diagnosis of MZL upon referral for imaging with [sup 18] F-FDG-PET were identified. Histological reassessment of biopsy specimens confirmed the diagnosis of extranodal MZL of MALT in 14 patients, while a diagnosis of nodal MZL was verified in 6 patients. Lymphoma cell proliferation was assessed immunohistochemically using a Ki-67 antibody. Whole-body [sup 18] F-FDG-PET scans were performed on a GE advanced PET scanner 40 min after intravenous injection of 300–380 MBq [sup 18] F-FDG. Results: None of the patients with extranodal MZL showed focal tracer uptake within verified tumor sites. In contrast, 5 of the 6 patients with nodal MZL showed significant FDG uptake within the affected lymph nodes. These results did not simply reflect the different growth fractions of the two lymphoma entities since the proliferation indices of the two groups did not differ significantly. Conclusion:[sup 18] F-FDG-PET visualizes nodal MZL in a high proportion of patients whereas FDG uptake is undetectable in extranodal MZL. Although limited by the small number of patients, this study suggests that imaging with [sup 18] F-FDG-PET might play a potential role in the diagnostic workup of patients with nodal MZL involvement.Copyright © 2003 S. Karger AG, Basel [ABSTRACT FROM AUTHOR]
- Published
- 2003
- Full Text
- View/download PDF
40. ACE inhibition is superior to angiotensin receptor blockade for renography in renal artery stenosis.
- Author
-
Karanikas, Georgios, Becherer, Alexander, Wiesner, Karoline, Dudczak, Robert, and Kletter, Kurt
- Subjects
ANGIOTENSIN converting enzyme ,CAPTOPRIL ,KIDNEY function tests - Abstract
Examines the superiority of angiotensin converting enzyme (ACE) to angiotensin receptor blockade for renography in renal artery stenosis. Demonstration of renovascular hypertension by captopril renography; Performance of captopril, valsartan, and baseline renography; Evaluation of the alterations in renographic curves after intervention.
- Published
- 2002
- Full Text
- View/download PDF
41. Tc-99m-labeled human polyclonal immunoglobulin G (HIG) scintigraphy in Sjögren's syndrome.
- Author
-
Karanikas, Georgios, Bobacz, Klaus, Becherer, Alexander, Wiesner, Karoline, Dudczak, Robert, MacHold, Klaus, and Kletter, Kurt
- Subjects
IMMUNOGLOBULIN G ,SJOGREN'S syndrome ,LUPUS erythematosus ,CLINICAL trials ,COMPARATIVE studies ,IMMUNOGLOBULINS ,RESEARCH methodology ,MEDICAL cooperation ,RADIOPHARMACEUTICALS ,RESEARCH ,TECHNETIUM compounds ,EVALUATION research ,SINGLE-photon emission computed tomography - Abstract
Objective: To evaluate the usefulness of Tc-99m-HIG scintigraphy in patients with Sjögren's syndrome.Methods: Twelve consecutive patients with verified secondary Sjögren's syndrome were included in this prospective study. The control group consisted of seven patients with Lupus erythematosus; none of them showed clinical signs of Sjögren's syndrome. Planar and SPECT images of the head were performed six hours after i.v. administration of Tc-99m HIG.Results: Eleven out of twelve patients with secondary Sjögren's syndrome showed a positive result, while one was false negative. Tracer accumulation in patients with positive scintigraphy varied. All patients of the control group were negative.Conclusion: Our data in a limited number of patients suggest that Tc-99m HIG scintigraphy could be a modality with high sensitivity and specificity for the diagnosis of Sjögren's syndrome and can provide objective information on the severity of the disease. [ABSTRACT FROM AUTHOR]- Published
- 2002
- Full Text
- View/download PDF
42. Effect of Near Physiologic Insulin Therapy on Hypoglycemia Counterregulation in Type-1 Diabetes.
- Author
-
Bischof, Martin G., Bernroider, Elisabeth, Ludwig, Claudia, Kurzemann, Susanne, Kletter, Kurt, Waldhäusl, Werner, and Roden, Michael
- Subjects
INSULIN ,PANCREATIC secretions ,HYPOGLYCEMIA ,DIABETES ,ENDOCRINE diseases ,FATTY acids - Abstract
Objectives: The aim of this study was to examine hormonal counterregulation during insulin-induced hypoglycemia in type-1 diabetic patients during long-term near normoglycemic insulin therapy and intensive clinical care. Methods: Type-1 diabetic patients (age 35.3 ± 2 years, body mass index 22.8 ± 1 kg·m[sup –2] , mean diabetes duration 13.6 (11–17 years), mean HbA1c during the last year 6.6 ± 0.1%) and nondiabetic subjects were studied during (0–120 min) and after (120–240 min) hypoglycemic (3.05 mmol/l) hyperinsulinemic (∼330 pmol/l) clamp tests. Results: During hypoglycemia peak plasma concentrations of glucagon (199 ± 16 vs. 155 ± 11 ng/l, p < 0.05), epinephrine (4,514 ± 644 vs. 1,676 ± 513 pmol/l, p < 0.001), norepinephrine (2.21 ± 0.14 vs. 1.35 ± 0.19 nmol/l, p < 0.01) and cortisol (532 ± 44 vs. 334 ± 61 nmol/l) were reduced in the diabetic patients. Plasma lactate did not change from baseline values (0.51 ± 0.06 mmol/l) in diabetic but doubled in healthy subjects (1.13 ± 0.111 mmol/l, p < 0.001 vs. control). During the posthypoglycemic recovery period plasma concentrations of free fatty acids were higher in diabetic patients at 240 min (1.34 ± 0.12 vs. 2.01 ± 0.23 mmol/l, p < 0.05). Conclusion: Despite long-term near physiologic insulin substitution and the low incidence of hypoglycemia, hormonal hypoglycemia counterregulation was impaired in type-1 diabetic patients after a diabetes duration of more than 10 years.Copyright © 2002 S. Karger AG, Basel [ABSTRACT FROM AUTHOR]
- Published
- 2001
- Full Text
- View/download PDF
43. [sup 18]F-Fluorodeoxyglucose (FDG)-PET features of focal nodular hyperplasia (FNH) of the liver.
- Author
-
Kurtaran, Amir, Becherer, Alexander, Pfeffel, Franz, Müller, Christian, Traub, Tatjana, Schmaljohann, Jörn, Kaserer, Klaus, Raderer, Markus, Schima, Wolfgang, Dudczak, Robert, Kletter, Kurt, and Virgolini, Irene
- Subjects
HYPERPLASIA ,LIVER tumors ,POSITRON emission tomography ,LIVER metastasis - Abstract
Aim: The aim of this paper is to describe the imaging pattern of focal nodular hyperplasia (FNH) by [sup 18]F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET). Methods: Eight consecutive asymptomatic patients with histologic proof of FNH underwent 18F-FDG PET imaging. The lesions were found incidentally. The 18F-FDG PET imaging was performed with a dedicated PET tomograph after intravenous injection of 300-370 MBq 18F-FDG. The 18F-FDG accumulation in the lesions was (semi)quantified by calculating the standardized uptake value (SUV) and SUV has been corrected for the lean body mass (LBM). Eight patients with liver metastases spread from melanoma (n=2) and colorectal carcinoma (n=6) served as controls. The size of the FNH lesions and of the control group ranged from 2.0 to 8.5 cm (mean 4.83 cm±2.37) and from 1.5 to 6 cm (mean 3.28±1.52), respectively. Results: While in malignant liver lesions the accumulation of 18F-FDG was significantly increased, all FNH lesions showed normal or even decreased accumulation of 18F-FDG. In FNH lesions, SUV ranged between 1.5 and 2.6 (mean 2.12±0.38), whereas all liver metastases showed an increased SUV ranging between 6.20 and 16.00 (mean 10.07±3.79). The SUV corrected for LMB (SUV[sub LBM]) was similar to the SUV and ranged between 0.9 and 2.2 (mean 1.81±0.41) for FNH and between 5.9 and 16.3 (mean 9.15±4.03), respectively. Conclusion: In contrast to liver metastases, there is no increased glucose metabolism in FNH in vivo. The imaging feature of FNH by 18F-FDG-PET imaging is not specific for FNH; however, it may be helpful to differentiate FNH from liver metastases in cancer patients if radiological methods are not diagnostic. [ABSTRACT FROM AUTHOR]
- Published
- 2000
- Full Text
- View/download PDF
44. Indium-111-DOTA-Lanreotide: Biodistribution, Safety and Radiation Absorbed Dose in Tumor Patients.
- Author
-
Virgolini, Irene, Szilvasi, Istvan, Kurtaran, Amir, Angelberger, Peter, Raderer, Markus, Havlik, Ernst, Vorbeck, Friedrich, Bischof, Claudia, Leimer, Maria, Dorner, Guido, Kletter, Kurt, Niederle, Bruno, Scheithauer, Werner, and Smith-Jones, Peter
- Published
- 1998
45. Inhalation Scintigraphy with Iodine-123-Labeled Interferon Gamma-1b: Pulmonary Deposition and Dose Escalation Study in Healthy Volunteers.
- Author
-
Virgolini, Irene, Kurtaran, Amir, Leimer, Maria, Smith-Jones, Peter, Agis, Hermine, Angelberger, Peter, Kletter, Kurt, Valent, Peter, Linkesch, Werner, and Eichler, Hans-Georg
- Published
- 1997
46. Comparison of Iodine-123-Vasoactive Intestinal Peptide Receptor Scintigraphy and Indium-111-CYT-103 Immunoscintigraphy.
- Author
-
Raderer, Markus, Becherer, Alexander, Kurtaran, Amir, Angelberger, Peter, Shuren Li, Leimer, Maria, Weinlaender, Georg, Kornek, Gabriela, Kletter, Kurt, Scheithauer, Werner, and Virgolini, Irene
- Published
- 1996
47. Small Bowel Function after Surgery for Chronic Radiation Enteritis.
- Author
-
Miholic, Johannes, Vogelsang, Harald, Schlappack, Otto, Kletter, Kurt, Szepesi, Tibor, and Moeschl, Peter
- Published
- 1989
- Full Text
- View/download PDF
48. Comparison and histopathological correlation of three parathyroid imaging methods in a population with a high prevalence of concomitant thyroid diseases.
- Author
-
Staudenherz, Anton, Abela, Claudette, Niederle, Bruno, Steiner, Erich, Helbich, Thomas, Puig, Stefan, Kaserer, Klaus, Becherer, Alexander, Leitha, Thomas, and Kletter, Kurt
- Abstract
The aim of this prospective study was to evaluate the diagnostic utility of a technetium-99m sestamibi dual-phase protocol enhanced by single-photon emission tomography (SPET) and semiquantitative analysis in comparison to established preoperative staging procedures in patients with primary hyperparathyroidism. Twenty-eight (50%) out of 56 patients had superimposed thyroid disease, and 12 patients had previously undergone neck surgery. Visual and semiquantitative analysis of planar
99m Tc-sestamibi dual-phase imaging, SPET of the delayed phase, ultrasonography, and thallium-201 chloride-technetium-99m pertechnetate subtraction scintigraphy was further correlated with the histopathological examination of the surgical specimens.99m Tc-sestamibi dual-phase imaging achieved the highest sensitivity for side localization and precise localization compared with201 Tl-99m Tc subtraction scintigraphy and ultrasonography, but the differences reached statistical significance only in comparison to ultrasonography. Semiquantitative analysis did not enhance sensitivity. Adenoma detection by99m Tc-sestamibi dual-phase imaging was only correlated to serum calcium levels and osteocalcin, not to cell density or oxyphil cell count (SPET yielded additional information for the exact topographical localization of the parathyroid tumour in 22 (39%) patients with superimposed thyroid disease or previous neck surgery but did not enhance the overall detection rate. [ABSTRACT FROM AUTHOR]- Published
- 1997
- Full Text
- View/download PDF
49. The use of I-labeled heptadecanoic acid (HDA) as metabolic tracer: Preliminary report.
- Author
-
Dudczak, Robert, Kletter, Kurt, Frischauf, Hans, Losert, Udo, Angelberger, Peter, and Schmoliner, Robert
- Abstract
The feasibility of using I-heptadecanoic acid (HDA) as a metabolic tracer was studied. Different administration routes of HDA were compared. An intracoronary bolus injection was given to calves ( n=3), and an intravenous injection was given to patients ( n=4). In addition, we examined the influence of 4-h halothane anesthesia in calves and in patients the impact of an insulin (1.5 IU/kg)+ glucose (1.5 g/kg) infusion on the myocardial kinetics of HDA. Data were accumulated with a scintillation probe in calves ( t=50 min) and a gamma camera in patients (t=70 min). In calves after an intracoronary bolus injection of HDA the myocardial time-activity curve could be described by two exponentials. The mean elimination halftime of the initial phase ( t 1/2) was 7.3 min and that of the second phase ( t 1/2) was 35 min. The ratio of the size of the initial and second component at t was 0.93. Halothane anesthesia prolonged the elimination half-times and reduced the component ratio. The biphasic behavior of the myocardial time-activity curve was maintained in patients after intravenous administration of HDA under basal conditions (initial t 1/2=8.4 min). However, during infusion of insulin+glucose the decline in the myocardial activity was prolonged and monoexponential. This data shows that insulin glucose, interfering with fatty acid metabolism, influences the myocardial washout of HDA, and thus support its use as a metabolic tracer. [ABSTRACT FROM AUTHOR]
- Published
- 1984
- Full Text
- View/download PDF
50. Functional Asplenia after Bone Marrow Transplantation.
- Author
-
Kalhs, Peter, Panzer, Simon, Kletter, Kurt, Minar, Erich, Stain-KOs, Milena, Walter, Reinhard, Lechner, Klaus, and Hinterberger, Wolfgang
- Subjects
BONE marrow transplantation ,GRAFT versus host disease - Abstract
Provides information on a study that evaluated splenic function in bone marrow transplant recipients, with relation to chronic graft-versus-host disease and infections. Methodology of the study; Results and discussion on the study.
- Published
- 1988
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.